I was born in 1953 in Philadelphia and grew up in New Jersey and Virginia. By the eighth grade, I had attended six public ...

Determining which cancer patients are a good candidate for immune checkpoint inhibitors can be a challenge, but researchers at Mount Sinai and Memorial Sloan Kettering Cancer Center have developed a ...

Discover the groundbreaking Cancer AI Alliance led by Fred Hutchinson and three other top cancer centers, utilizing patient data to revolutionize cancer care ...

NATICK, Mass., Jan. 7, 2025 /PRNewswire/ -- Pillar Biosciences, Inc. has entered into a strategic five-year licensing ...

"Amy and I co-founded Highlander Health to solve big challenges in health care and the acquisition of Target RWE is an important step in that endeavor," said Brad Hirsch, Highlander Health co-founder.

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will ...

The one-and-a-half-day symposium provides an overview of recent advances in the treatment of solid tumors with novel targeted agents and treatment combinations, as well as evolving molecular-based ...

Medical advancements make early-detected cancers more manageable and treatable, with immunotherapy and CAR T cell therapy ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of immunotherapy - ...